Discoloration Defense

Skin discoloration serum

$98.00

Daily dark spot corrector targets visible skin discoloration for brighter, more even-looking skin

Product Details

  • 3% Tranexamic Acid
    This synthetically-derived ingredient minimizes the reoccurrence of skin discoloration and stubborn brown patches with continued use.
  • 1% Kojic Acid
    Naturally produced by certain fungi, kojic acid helps improve skin brightness.
  • 5% Niacinamide
    Also known as vitamin B3, this water-soluble vitamin is found naturally in yeast, meat, fish, milk, eggs, green vegetables, beans, and cereal grains. It has been shown to help reduce the appearance of skin discoloration.
  • 5% HEPES
    This synthetically-derived acid activates natural enzymes in skin to help break the bonds that bind dead skin cells to the surface for even exfoliation.

Twice daily, apply 3-5 drops of this skin discoloration serum to the face. 

  • If using in the morning, apply after a SkinCeuticals vitamin C serum and follow with a SkinCeuticals broad spectrum SPF 50+ sunscreen. 
  • Limit sun exposure while using this product. 
  • Do not use on irritated or broken skin. If irritation occurs, discontinue use. 

 

Discoloration Defense is a layerable, daily-use dark spot corrector clinically proven to reduce the appearance of key types of skin discoloration in all skin tones, including hard-to-treat forms such as stubborn brown patches and post-acne marks. Formulated with 3% tranexamic acid, 1% kojic acid, 5% niacinamide, and 5% HEPES, this latest-generation formula improves the appearance of skin discoloration, brightens skin, and evens skin tone in as early as 2 weeks.

I recommend Discoloration Defense between chemical peels- this formula targets stubborn types of discoloration but is gentle on my patients’ skin, making it ideal for an at-home regimen between treatments. 

Dr. Sarah Sawyer

1 In a 12-week clinical study, Discoloration Defense significantly improved the appearance of key skin discoloration markers:

  • 60% average improvement in the appearance of stubborn brown patches
  • 59% average improvement in the appearance of skin discoloration
  • 81% average improvement in the appearance of post-acne marks
  • 59% average improvement in the appearance of even skin tone

 

2 In a new 12-week study on deeper skin tones (Fitzpatrick V-VI), twice-daily application of Discoloration Defense demonstrated a statistically-significant reduction in the appearance of discoloration, post-inflammatory discoloration, and even skin tone.

  • 34% reduction in post-blemish marks at 12 weeks

Dry, Normal, Oily, Combination

 Discoloration

 Discoloration

Key Benefits

  • Features a synergistic blend of anti-discoloration ingredients to reduce the appearance of skin discoloration, improve brightness, and minimize the reoccurrence of discoloration (with continued use)
  • 60% average improvement in the appearance of stubborn brown patches1
  • 34% average reduction in post-blemish marks in deeper skin tones2
  • Paraben-, fragrance-, silicone-, gluten-, and hydroquinone-free
  • Ideal at-home complement to professional skin discoloration treatments, such as chemical peels or non-ablative laser; always consult with a physician for individual regimen recommendations1Protocol: Average results shown. A 12-week, single-center, clinical study was conducted on 50 females, ages 25 to 60, Fitzpatrick I-IV, with mild to moderate facial skin discoloration, including stubborn dark spots, post-acne marks, and uneven skin tone. Discoloration Defense was applied to the face twice a day in conjunction with a sunscreen. Efficacy and tolerability evaluations were conducted at baseline and at weeks 2, 4, 8, and 12.

    2Protocol: A 12-week, single-center, clinical study was conducted on 51 female subjects, Fitzpatrick V-VI, with visible signs of skin discoloration/hyperpigmentation, including post-inflammatory hyperpigmentation and melasma. Discoloration Defense was applied to the face twice a day in conjunction with a sunscreen. Efficacy and tolerability evaluations were conducted at baseline and at weeks 2, 4, 8, and 12.